| Field | Row 1 |
|---|---|
| adsh | 0001171843-25-002953 |
| cik | 1738021 |
| name | COMPASS THERAPEUTICS, INC. |
| sic | 2836 |
| countryba | US |
| stprba | MA |
| cityba | BOSTON |
| zipba | 02135 |
| bas1 | 80 GUEST STREET |
| bas2 | |
| baph | 617-500-8099 |
| countryma | US |
| stprma | MA |
| cityma | BOSTON |
| zipma | 02135 |
| mas1 | 80 GUEST STREET |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 000000000 |
| former | OLIVIA VENTURES, INC. |
| changed | 20180419 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250508 |
| accepted | 2025-05-08 08:01:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | cmpx20250331_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001171843-25-002953 | 20241231 | Additional Paid In Capital Common Stock | 489692000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Accounts Payable Current | 1577000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Accrued Liabilities Current | 6287000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Accumulated Other Comprehensive Income Loss Net Of Tax | 190000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2003000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2514000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20250331 | Assets | 131451000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2025 | ||||
| 0001171843-25-002953 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Common Stock Shares Outstanding | 138282000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Comprehensive Income Net Of Tax | -16653000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | General And Administrative Expense | 3248000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | General And Administrative Expense | 1611000.0000 | USD | 1 | us-gaap/2025 | Nature Of Expense= General; | ||
| 0001171843-25-002953 | 20250331 | General And Administrative Expense | 1707000.0000 | USD | 1 | us-gaap/2025 | Nature Of Expense= Stock Based Compensation; | ||
| 0001171843-25-002953 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -10787000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Increase Decrease In Accrued Liabilities | -699000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Increase Decrease In Accrued Liabilities | 6927000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Marketable Securities Unrealized Gain Loss | -20000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Cash Provided By Used In Financing Activities | -815000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Income Loss | -16633000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Prepaid Expense And Other Assets Current | 11510000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Proceeds From Sale And Maturity Of Marketable Securities | 36438000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Restricted Cash | 568000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20231231 | Stockholders Equity | 148538000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Stockholders Equity | -364683000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20250331 | Stockholders Equity | 14000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Shares New Issues | 9790000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20241231 | Accounts Payable Current | 2249000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 43803000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -2435000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Common Stock Shares Outstanding | 137820000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | General And Administrative Expense | 4912000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Increase Decrease In Accounts Payable | -672000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Increase Decrease In Operating Lease Liability | -253000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Liabilities | 21172000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Marketable Securities Current | 71587000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Net Cash Provided By Used In Financing Activities | 17433000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Cash Provided By Used In Operating Activities | -13208000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Net Income Loss | -10787000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Income Loss | -16633000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Operating Income Loss | -12770000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Operating Lease Liability Noncurrent | 6296000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Operating Lease Right Of Use Asset | 6731000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 224000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Payments Related To Tax Withholding For Share Based Compensation | 136000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Payments To Acquire Marketable Securities | 41878000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20231231 | Shares Outstanding | 127668000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20241231 | Shares Outstanding | 137820000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Shares Outstanding | 138282000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20241231 | Stockholders Equity | 14000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value Share Based Compensation | -136000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20250331 | Accrued Liabilities Current | 13214000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Assets | 140403000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Cash And Cash Equivalents At Carrying Value | 41048000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 41616000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 41616000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Common Stock Shares Issued | 137820000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Increase Decrease In Operating Lease Liability | -320000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Liabilities And Stockholders Equity | 131451000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Liabilities Current | 8874000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Marketable Securities Current | 83239000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Net Cash Provided By Used In Investing Activities | -4099000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20250331 | Operating Lease Liability Noncurrent | 6272000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 309000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Other Nonoperating Income Expense | 1983000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Payments Related To Tax Withholding For Share Based Compensation | 815000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Research And Development Expense Excluding Acquired In Process Cost | 13054000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Share Based Compensation | 2514000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Stockholders Equity | 157060000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Stockholders Equity | 483231000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20241231 | Stockholders Equity | 210000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 44051000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Common Stock Shares Authorized | 300000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Common Stock Value | 14000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Comprehensive Income Net Of Tax | -10914000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -16633000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Liabilities Current | 14900000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20250331 | Other Nonoperating Income Expense | 1333000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Payments To Acquire Marketable Securities | 24832000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Payments To Acquire Property Plant And Equipment | 18000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Restricted Cash And Cash Equivalents | 568000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Retained Earnings Accumulated Deficit | -364683000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Share Based Compensation | 2003000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Shares Outstanding | 137589000.0000 | shares | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Stock Issued During Period Shares Share Based Compensation | -815000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 462000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value New Issues | 17568000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 136608000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Restricted Cash | 568000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Restricted Cash And Cash Equivalents | 320000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | 500000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Cash And Cash Equivalents At Carrying Value | 43483000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Depreciation And Amortization | 140000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | General And Administrative Expense | 944000.0000 | USD | 1 | us-gaap/2025 | Nature Of Expense= Personnel; | ||
| 0001171843-25-002953 | 20240331 | Marketable Securities Amortization Of Premium And Discount | -376000.0000 | USD | 1 | 0001171843-25-002953 | |||
| 0001171843-25-002953 | 20240331 | Marketable Securities Unrealized Gain Loss | -127000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Cash Provided By Used In Investing Activities | 11588000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20241231 | Operating Lease Liability Current | 338000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -127000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Payments Of Stock Issuance Costs | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Proceeds From Issuance Of Common Stock | 18113000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Property Plant And Equipment Net | 231000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20231231 | Stockholders Equity | 13000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Stockholders Equity | 14000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 131000.0000 | shares | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Stock Issued During Period Value Share Based Compensation | -815000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20241231 | Accumulated Other Comprehensive Income Loss Net Of Tax | 210000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2514000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Assets Current | 132751000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Cash And Cash Equivalents At Carrying Value | 43483000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 23994000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2003000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 24548000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -554000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Common Stock Shares Authorized | 300000000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Common Stock Value | 14000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Liabilities And Stockholders Equity | 140403000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Marketable Securities Amortization Of Premium And Discount | 26000.0000 | USD | 1 | 0001171843-25-002953 | |||
| 0001171843-25-002953 | 20240331 | Net Cash Provided By Used In Operating Activities | -13888000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Operating Expenses | 12770000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Operating Income Loss | -17966000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Operating Lease Right Of Use Asset | 6507000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -127000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20240331 | Proceeds From Sale And Maturity Of Marketable Securities | 37779000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240930 | Restricted Cash | 568000.0000 | USD | 0 | us-gaap/2025 | Guarantee Obligations By Nature= Financial Standby Letter Of Credit; Lease Contractual Term= Facility Lease; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value New Issues | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20250331 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Depreciation And Amortization | 154000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Earnings Per Share Basic | -0.1200 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | General And Administrative Expense | 1079000.0000 | USD | 1 | us-gaap/2025 | Nature Of Expense= Stock Based Compensation; | ||
| 0001171843-25-002953 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 5481000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Liabilities | 15170000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20240331 | Net Income Loss | -10787000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20250331 | Operating Expenses | 17966000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -20000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -20000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20231231 | Stockholders Equity | 463796000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20231231 | Stockholders Equity | -315308000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Stockholders Equity | -90000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20241231 | Stockholders Equity | 489692000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20250331 | Stockholders Equity | -381316000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value New Issues | 17569000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 138236000.0000 | shares | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20250331 | Assets Current | 124145000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Additional Paid In Capital Common Stock | 491391000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Common Stock Shares Issued | 138282000.0000 | shares | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Earnings Per Share Basic | -0.0800 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | General And Administrative Expense | 1225000.0000 | USD | 1 | us-gaap/2025 | Nature Of Expense= General; | ||
| 0001171843-25-002953 | 20250331 | General And Administrative Expense | 1594000.0000 | USD | 1 | us-gaap/2025 | Nature Of Expense= Personnel; | ||
| 0001171843-25-002953 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Increase Decrease In Accounts Payable | -3236000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 936000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Operating Lease Liability Current | 109000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Operating Lease Right Of Use Asset | 6500000.0000 | USD | 0 | us-gaap/2025 | Lease Contractual Term= Facility Lease; | ||
| 0001171843-25-002953 | 20240331 | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20240331 | Payments Of Stock Issuance Costs | 544000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Payments To Acquire Property Plant And Equipment | 0.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Prepaid Expense And Other Assets Current | 6029000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20241231 | Property Plant And Equipment Net | 353000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Research And Development Expense Excluding Acquired In Process Cost | 9522000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value New Issues | 1000.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; | ||
| 0001171843-25-002953 | 20250331 | Retained Earnings Accumulated Deficit | -381316000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20231231 | Stockholders Equity | 37000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20240331 | Stockholders Equity | -326095000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Retained Earnings; | ||
| 0001171843-25-002953 | 20241231 | Stockholders Equity | 125233000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Stockholders Equity | 110279000.0000 | USD | 0 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20250331 | Stockholders Equity | 190000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Accumulated Other Comprehensive Income; | ||
| 0001171843-25-002953 | 20250331 | Stockholders Equity | 491391000.0000 | USD | 0 | us-gaap/2025 | Equity Components= Additional Paid In Capital; | ||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value Share Based Compensation | -136000.0000 | USD | 1 | us-gaap/2025 | |||
| 0001171843-25-002953 | 20240331 | Stock Issued During Period Value Share Based Compensation | 0.0000 | USD | 1 | us-gaap/2025 | Equity Components= Common Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Investing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash and Cash Equivalent | Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Common Stock Shares Authorized | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Property Plant And Equipment Net | us-gaap/2025 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation | Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| General And Administrative Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Commitments And Contingencies | us-gaap/2025 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Increase Decrease In Operating Lease Liability | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Common Stock Shares Issued | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Increase Decrease In Accounts Payable | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Payment, Tax Withholding, Share-Based Payment Arrangement | Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement. |
| Stock Issued During Period Value Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | C | Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Operating Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Marketable Securities Amortization Of Premium And Discount | 0001171843-25-002953 | 1 | 0 | monetary | D | D | cmpx_MarketableSecuritiesAmortizationOfPremiumAndDiscount | Represents amortization of premium and discount for marketable securities . |
| Comprehensive Income Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. |
| Operating Expenses | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | D | C | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. |
| Payments To Acquire Marketable Securities | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. |
| Restricted Cash | us-gaap/2025 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Operating Lease Liability Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Operating Lease Right Of Use Asset | us-gaap/2025 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Payments Of Stock Issuance Costs | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Accrued Liabilities Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Earnings Per Share Basic | us-gaap/2025 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Payments To Acquire Property Plant And Equipment | us-gaap/2025 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Restricted Cash And Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Restricted Cash and Cash Equivalent | Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Stock Issued During Period Shares New Issues | us-gaap/2025 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Net Cash Provided By Used In Financing Activities | us-gaap/2025 | 0 | 0 | monetary | D | D | Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit. |
| Common Stock Shares Outstanding | us-gaap/2025 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Depreciation And Amortization | us-gaap/2025 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Marketable Securities Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Marketable Securities, Current | Amount of investment in marketable security, classified as current. |
| Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2025 | 0 | 0 | monetary | D | D | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. |
| Assets | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Liabilities And Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Net Income Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Other Nonoperating Income Expense | us-gaap/2025 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Stockholders Equity | us-gaap/2025 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2025 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | 0 | 0 | monetary | I | C | Accumulated Other Comprehensive Income (Loss), Net of Tax | Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source. |
| Prepaid Expense And Other Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2025 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Net Cash Provided By Used In Operating Activities | us-gaap/2025 | 0 | 0 | monetary | D | Cash Provided by (Used in) Operating Activity, Including Discontinued Operation | Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity. | |
| Assets Current | us-gaap/2025 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Income Tax Expense Benefit | us-gaap/2025 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Liabilities | us-gaap/2025 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Increase Decrease In Accrued Liabilities | us-gaap/2025 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Share Based Compensation | us-gaap/2025 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Accounts Payable Current | us-gaap/2025 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Additional Paid In Capital Common Stock | us-gaap/2025 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | 0 | 0 | monetary | I | D | Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. |
| Marketable Securities Unrealized Gain Loss | us-gaap/2025 | 0 | 0 | monetary | D | C | Marketable Security, Unrealized Gain (Loss) | Amount of unrealized gain (loss) on investment in marketable security. |
| Retained Earnings Accumulated Deficit | us-gaap/2025 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Common Stock Value | us-gaap/2025 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Stock Issued During Period Value New Issues | us-gaap/2025 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2025 | 0 | 0 | monetary | D | D | Research and Development Expense (Excluding Acquired in Process Cost) | Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001171843-25-002953 | 2 | 4 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001171843-25-002953 | 2 | 5 | BS | 0 | H | Marketable Securities Current | us-gaap/2025 | Marketable securities | 0 |
| 0001171843-25-002953 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001171843-25-002953 | 2 | 7 | BS | 0 | H | Assets Current | us-gaap/2025 | Total current assets | 0 |
| 0001171843-25-002953 | 2 | 8 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2025 | Property and equipment, net | 0 |
| 0001171843-25-002953 | 2 | 9 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2025 | Operating lease, right-of-use ("ROU") asset | 0 |
| 0001171843-25-002953 | 2 | 10 | BS | 0 | H | Restricted Cash | us-gaap/2025 | Restricted cash | 0 |
| 0001171843-25-002953 | 2 | 11 | BS | 0 | H | Assets | us-gaap/2025 | Total assets | 0 |
| 0001171843-25-002953 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2025 | Accounts payable | 0 |
| 0001171843-25-002953 | 2 | 14 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2025 | Accrued expenses | 0 |
| 0001171843-25-002953 | 2 | 15 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2025 | Operating lease obligations, current portion | 0 |
| 0001171843-25-002953 | 2 | 16 | BS | 0 | H | Liabilities Current | us-gaap/2025 | Total current liabilities | 0 |
| 0001171843-25-002953 | 2 | 17 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2025 | Operating lease obligations, long-term portion | 0 |
| 0001171843-25-002953 | 2 | 18 | BS | 0 | H | Liabilities | us-gaap/2025 | Total liabilities | 0 |
| 0001171843-25-002953 | 2 | 19 | BS | 0 | H | Commitments And Contingencies | us-gaap/2025 | Commitments and Contingencies | 0 |
| 0001171843-25-002953 | 2 | 21 | BS | 0 | H | Common Stock Value | us-gaap/2025 | Common stock, $0.0001 par value: 300,000 shares authorized; 138,282 and 137,820 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001171843-25-002953 | 2 | 22 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2025 | Additional paid-in-capital | 0 |
| 0001171843-25-002953 | 2 | 23 | BS | 0 | H | Accumulated Other Comprehensive Income Loss Net Of Tax | us-gaap/2025 | Accumulated other comprehensive income | 0 |
| 0001171843-25-002953 | 2 | 24 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2025 | Accumulated deficit | 0 |
| 0001171843-25-002953 | 2 | 25 | BS | 0 | H | Stockholders Equity | us-gaap/2025 | Total stockholders' equity | 0 |
| 0001171843-25-002953 | 2 | 26 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2025 | Total liabilities and stockholders' equity | 0 |
| 0001171843-25-002953 | 3 | 3 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2025 | Common Stock, Par or Stated Value Per Share (in dollars per share) | 0 |
| 0001171843-25-002953 | 3 | 4 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2025 | Common Stock, Shares Authorized (in shares) | 0 |
| 0001171843-25-002953 | 3 | 5 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2025 | Common Stock, Shares, Outstanding (in shares) | 0 |
| 0001171843-25-002953 | 3 | 6 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2025 | Common Stock, Shares, Issued (in shares) | 0 |
| 0001171843-25-002953 | 4 | 4 | IS | 0 | H | Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2025 | Research and development | 0 |
| 0001171843-25-002953 | 4 | 5 | IS | 0 | H | General And Administrative Expense | us-gaap/2025 | General and administrative | 0 |
| 0001171843-25-002953 | 4 | 6 | IS | 0 | H | Operating Expenses | us-gaap/2025 | Total operating expenses | 0 |
| 0001171843-25-002953 | 4 | 7 | IS | 0 | H | Operating Income Loss | us-gaap/2025 | Loss from operations | 0 |
| 0001171843-25-002953 | 4 | 8 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2025 | Other income | 0 |
| 0001171843-25-002953 | 4 | 9 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2025 | Loss before income tax expense | 0 |
| 0001171843-25-002953 | 4 | 10 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2025 | Income tax expense | 0 |
| 0001171843-25-002953 | 4 | 11 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001171843-25-002953 | 4 | 12 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2025 | Net loss per share - basic and diluted (in dollars per share) | 0 |
| 0001171843-25-002953 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2025 | Basic and diluted weighted average shares outstanding (in shares) | 0 |
| 0001171843-25-002953 | 4 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001171843-25-002953 | 4 | 16 | IS | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2025 | Unrealized loss on marketable securities | 0 |
| 0001171843-25-002953 | 4 | 17 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2025 | Comprehensive loss | 0 |
| 0001171843-25-002953 | 5 | 9 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in shares) | 0 |
| 0001171843-25-002953 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001171843-25-002953 | 5 | 11 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2025 | Share-based awards, net of tax remittance (in shares) | 0 |
| 0001171843-25-002953 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value Share Based Compensation | us-gaap/2025 | Share-based awards, net of tax remittance | 0 |
| 0001171843-25-002953 | 5 | 13 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2025 | Stock-based compensation | 0 |
| 0001171843-25-002953 | 5 | 14 | EQ | 0 | H | Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | us-gaap/2025 | Unrealized loss on marketable securities | 0 |
| 0001171843-25-002953 | 5 | 15 | EQ | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001171843-25-002953 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2025 | Common shares issued, net of issuance costs of $0.5 million (in shares) | 0 |
| 0001171843-25-002953 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2025 | Common shares issued, net of issuance costs of $0.5 million | 0 |
| 0001171843-25-002953 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2025 | Balance (in shares) | 0 |
| 0001171843-25-002953 | 5 | 19 | EQ | 0 | H | Stockholders Equity | us-gaap/2025 | Balance | 0 |
| 0001171843-25-002953 | 6 | 3 | EQ | 1 | H | Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | us-gaap/2025 | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | 0 |
| 0001171843-25-002953 | 7 | 4 | CF | 0 | H | Net Income Loss | us-gaap/2025 | Net loss | 0 |
| 0001171843-25-002953 | 7 | 6 | CF | 0 | H | Depreciation And Amortization | us-gaap/2025 | Depreciation and amortization | 0 |
| 0001171843-25-002953 | 7 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2025 | Share-based compensation | 0 |
| 0001171843-25-002953 | 7 | 8 | CF | 0 | H | Marketable Securities Amortization Of Premium And Discount | 0001171843-25-002953 | Amortization of premium and discount on marketable securities | 0 |
| 0001171843-25-002953 | 7 | 9 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2025 | ROU asset amortization | 0 |
| 0001171843-25-002953 | 7 | 11 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2025 | Prepaid expenses and other current assets | 0 |
| 0001171843-25-002953 | 7 | 12 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2025 | Accounts payable | 0 |
| 0001171843-25-002953 | 7 | 13 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2025 | Accrued expenses | 0 |
| 0001171843-25-002953 | 7 | 14 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2025 | Operating lease liability | 0 |
| 0001171843-25-002953 | 7 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2025 | Net cash used in operating activities | 0 |
| 0001171843-25-002953 | 7 | 17 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2025 | Purchase of property and equipment | 1 |
| 0001171843-25-002953 | 7 | 18 | CF | 0 | H | Payments To Acquire Marketable Securities | us-gaap/2025 | Purchases of marketable securities | 1 |
| 0001171843-25-002953 | 7 | 19 | CF | 0 | H | Proceeds From Sale And Maturity Of Marketable Securities | us-gaap/2025 | Proceeds from sale or maturities of marketable securities | 0 |
| 0001171843-25-002953 | 7 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2025 | Net cash provided by (used in) investing activities | 0 |
| 0001171843-25-002953 | 7 | 22 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2025 | Proceeds from issuance of common stock | 1 |
| 0001171843-25-002953 | 7 | 23 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2025 | Issuance costs from issuance of common stock | 1 |
| 0001171843-25-002953 | 7 | 24 | CF | 0 | H | Payments Related To Tax Withholding For Share Based Compensation | us-gaap/2025 | Taxes paid related to net shares settlement of RSUs | 1 |
| 0001171843-25-002953 | 7 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2025 | Net cash provided by (used in) financing activities | 0 |
| 0001171843-25-002953 | 7 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2025 | Net change in cash and cash equivalents and restricted cash | 0 |
| 0001171843-25-002953 | 7 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | Cash and cash equivalents and restricted cash at beginning of period | 0 |
| 0001171843-25-002953 | 7 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2025 | Cash and cash equivalents and restricted cash at end of period | 0 |
| 0001171843-25-002953 | 7 | 30 | CF | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2025 | Cash and cash equivalents | 0 |
| 0001171843-25-002953 | 7 | 31 | CF | 0 | H | Restricted Cash And Cash Equivalents | us-gaap/2025 | Restricted cash | 0 |
| 0001171843-25-002953 | 7 | 32 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2025 | Total cash, cash equivalents and restricted cash | 0 |
| 0001171843-25-002953 | 7 | 34 | CF | 0 | H | Marketable Securities Unrealized Gain Loss | us-gaap/2025 | Unrealized loss on marketable securities | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |